ClinicalTrials.gov
ClinicalTrials.gov Menu

Chemotherapy With DNA Damaging Agents In Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01456923
Recruitment Status : Completed
First Posted : October 21, 2011
Last Update Posted : October 21, 2011
Sponsor:
Information provided by (Responsible Party):
Ana Cadavez Pedro, Centro Hospitalar Nordeste

October 18, 2011
October 21, 2011
October 21, 2011
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Chemotherapy With DNA Damaging Agents In Colorectal Cancer
Phase 1 Study Of The Efficacy Of Chemotherapy With DNA Damaging Agents Versus Surgery In Colorectal Cancer
Chemotherapy Treatment alone with DNA damaging drugs might be as effective as chemotherapy combined with surgery in colorectal cancer (CRC) avoiding surgery complications.
Not Provided
Interventional
Phase 1
Primary Purpose: Treatment
Colorectal Cancer
  • Other: Treatment with chemotherapy
  • Other: Only chemotherapy treatment for study cohort
    Control patients were treated both with surgery and chemotherapy. Study patients were treated only with chemotherapy
  • Procedure: surgery
  • Active Comparator: Control (chemotherapy and surgery)
    Patients treated with chemotherapy + surgery
    Interventions:
    • Other: Treatment with chemotherapy
    • Procedure: surgery
  • Active Comparator: Study
    Patients treated only with chemotherapy
    Intervention: Other: Only chemotherapy treatment for study cohort
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

- patients that did not underwent surgery

Exclusion Criteria:

- patients that underwent surgery

Sexes Eligible for Study: All
40 Years to 90 Years   (Adult, Older Adult)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01456923
ACCRC10
Not Provided
Not Provided
Not Provided
Ana Cadavez Pedro, Centro Hospitalar Nordeste
Centro Hospitalar Nordeste
Not Provided
Not Provided
Centro Hospitalar Nordeste
September 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP